Prestige Consumer Healthcare Inc (NYSE:PBH) – Research analysts at Jefferies Financial Group raised their FY2019 earnings per share (EPS) estimates for shares of Prestige Consumer Healthcare in a note issued to investors on Thursday, November 1st. Jefferies Financial Group analyst S. Wissink now anticipates that the company will earn $2.89 per share for the year, up from their previous forecast of $2.86. Jefferies Financial Group has a “Hold” rating and a $38.00 price objective on the stock. Jefferies Financial Group also issued estimates for Prestige Consumer Healthcare’s Q1 2020 earnings at $0.68 EPS and Q2 2020 earnings at $0.73 EPS.
Several other analysts have also recently issued reports on the company. ValuEngine upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research note on Thursday, October 11th. Zacks Investment Research cut Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 10th. Finally, DA Davidson upped their price objective on Prestige Consumer Healthcare to $38.00 and gave the company a “neutral” rating in a research note on Monday. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $72.40.
Shares of NYSE PBH opened at $40.58 on Monday. Prestige Consumer Healthcare has a 52-week low of $27.84 and a 52-week high of $48.24. The company has a market cap of $1.95 billion, a price-to-earnings ratio of 15.73, a PEG ratio of 1.87 and a beta of 1.04. The company has a debt-to-equity ratio of 1.59, a quick ratio of 1.38 and a current ratio of 2.15.
Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, November 1st. The company reported $0.65 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.02. Prestige Consumer Healthcare had a return on equity of 11.82% and a net margin of 33.38%. The business had revenue of $239.36 million for the quarter, compared to analysts’ expectations of $236.28 million. During the same quarter in the previous year, the firm posted $0.61 earnings per share. The company’s revenue was down 7.2% compared to the same quarter last year.
A number of hedge funds and other institutional investors have recently made changes to their positions in PBH. Bank of Montreal Can raised its stake in Prestige Consumer Healthcare by 135.9% during the second quarter. Bank of Montreal Can now owns 3,067 shares of the company’s stock valued at $118,000 after buying an additional 1,767 shares in the last quarter. Zions Bancorporation acquired a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter worth approximately $137,000. BlueMountain Capital Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter worth approximately $208,000. Public Employees Retirement Association of Colorado raised its position in shares of Prestige Consumer Healthcare by 73.8% during the 3rd quarter. Public Employees Retirement Association of Colorado now owns 5,623 shares of the company’s stock worth $213,000 after purchasing an additional 2,387 shares during the period. Finally, Parametrica Management Ltd acquired a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter worth approximately $217,000.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Featured Story: Market Capitalization and Individual Investors
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.